Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Kiyoi, H; Naoe, T
   Immunoglobulin variable region structure and B-cell malignancies
   INTERNATIONAL JOURNAL OF HEMATOLOGY
   
   H. Kiyoi e T. Naoe, "Immunoglobulin variable region structure and B-cell malignancies", INT J HEMAT, 73(1), 2001, pp. 47-53
2. Hanamura, I; Iida, S; Akano, Y; Hayami, Y; Kato, M; Miura, K; Harada, S; Banno, S; Wakita, A; Kiyoi, H; Naoe, T; Shimizu, S; Sonta, S; Nitta, M; Taniwaki, M; Ueda, R
   Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations
   JAPANESE JOURNAL OF CANCER RESEARCH
   
   I. Hanamura et al., "Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations", JPN J CANC, 92(6), 2001, pp. 638-644
3. Kosugi, H; Ito, M; Yamamoto, Y; Towatari, M; Ito, M; Ueda, R; Saito, H; Naoe, T
   In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice
   JAPANESE JOURNAL OF CANCER RESEARCH
   
   H. Kosugi et al., "In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD/Shi-scid/scid mice", JPN J CANC, 92(5), 2001, pp. 529-536
4. Kunishima, S; Naoe, T; Kamiya, T; Saito, H
   Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder
   AMERICAN JOURNAL OF HEMATOLOGY
   
   S. Kunishima et al., "Novel heterozygous missense mutation in the platelet glycoprotein Ib beta gene associated with isolated giant platelet disorder", AM J HEMAT, 68(4), 2001, pp. 249-255
5. Naoe, T; Kiyoi, H; Yamamoto, Y; Minami, Y; Yamamoto, K; Ueda, R; Saito, H
   FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy
   CANCER CHEMOTHERAPY AND PHARMACOLOGY
   
   T. Naoe et al., "FLT3 tyrosine kinase as a target molecule for selective antileukemia therapy", CANC CHEMOT, 48, 2001, pp. S27-S30
6. Hirose, Y; Kiyoi, H; Itoh, K; Kato, K; Saito, H; Naoe, T
   B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells
   IMMUNOLOGY
   
   Y. Hirose et al., "B-cell precursors differentiated from cord blood CD34(+) cells are more immature than those derived from granulocyte colony-stimulating factor-mobilized peripheral blood CD34(+) cells", IMMUNOLOGY, 104(4), 2001, pp. 410-417
7. Yamamoto, Y; Kiyoi, H; Nakano, Y; Suzuki, R; Kodera, Y; Miyawaki, S; Asou, N; Kuriyama, K; Yagasaki, F; Shimazaki, C; Akiyama, H; Saito, K; Nishimura, M; Motoji, T; Shinagawa, K; Takeshita, A; Saito, H; Ueda, R; Ohno, R; Naoe, T
   Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies
   BLOOD
   
   Y. Yamamoto et al., "Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies", BLOOD, 97(8), 2001, pp. 2434-2439
8. Naoe, T; Takeyama, K; Yokozawa, T; Kiyoi, H; Seto, M; Uike, N; Ino, T; Utsunomiya, A; Maruta, A; Jin-Nai, I; Kamada, N; Kubota, Y; Nakamura, H; Shimazaki, C; Horiike, S; Kodera, Y; Saito, H; Ueda, R; Wiemels, J; Ohno, R
   Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia
   CLINICAL CANCER RESEARCH
   
   T. Naoe et al., "Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related Leukemia/Myelodysplastic Syndrome and de novo acute myeloid leukemia", CLIN CANC R, 6(10), 2000, pp. 4091-4095
9. Naoe, T; Nakano, Y; Kiyoi, H
   Leukemia relapse reconsidered from the molecular aspect
   LEUKEMIA & LYMPHOMA
   
   T. Naoe et al., "Leukemia relapse reconsidered from the molecular aspect", LEUK LYMPH, 37(5-6), 2000, pp. 527-534
10. Hayakawa, F; Towatari, M; Kiyoi, H; Tanimoto, M; Kitamura, T; Saito, H; Naoe, T
    Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
    ONCOGENE
    
    F. Hayakawa et al., "Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines", ONCOGENE, 19(5), 2000, pp. 624-631
11. Murata, M; Towatari, M; Kosugi, H; Tanimoto, M; Ueda, R; Saito, H; Naoe, T
    Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells
    JAPANESE JOURNAL OF CANCER RESEARCH
    
    M. Murata et al., "Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells", JPN J CANC, 91(11), 2000, pp. 1154-1160
12. Nakano, Y; Naoe, T; Kiyoi, H; Kitamura, K; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Kusumoto, S; Shimazaki, C; Akiyama, H; Saito, K; Nishimura, M; Motoji, T; Shinagawa, K; Saito, H; Ohno, R
    Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    Y. Nakano et al., "Prognostic value of p53 gene mutations and the product expression in de novo acute myeloid leukemia", EUR J HAEMA, 65(1), 2000, pp. 23-31
13. Zhao, M; Kiyoi, H; Yamamoto, Y; Ito, M; Towatari, M; Omura, S; Kitamura, T; Ueda, R; Saito, H; Naoe, T
    In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor
    LEUKEMIA
    
    M. Zhao et al., "In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor", LEUKEMIA, 14(3), 2000, pp. 374-378
14. Kitamura, K; Minami, Y; Yamamoto, K; Akao, Y; Kiyoi, H; Saito, H; Naoe, T
    Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis
    LEUKEMIA
    
    K. Kitamura et al., "Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis", LEUKEMIA, 14(10), 2000, pp. 1743-1750
15. Yokozawa, T; Towatari, M; Iida, H; Takeyama, K; Tanimoto, M; Kiyoi, H; Motoji, T; Asou, N; Saito, K; Takeuchi, M; Kobayashi, Y; Miyawaki, S; Kodera, Y; Ohno, R; Saito, H; Naoe, T
    Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia
    LEUKEMIA
    
    T. Yokozawa et al., "Prognostic significance of the cell cycle inhibitor p27(Kip1) in acute myeloid leukemia", LEUKEMIA, 14(1), 2000, pp. 28-33
16. Mason, R; Nakase, N; Naoe, T
    Craft education in lower secondary schools in England and Japan: a comparative study
    COMPARATIVE EDUCATION
    
    R. Mason et al., "Craft education in lower secondary schools in England and Japan: a comparative study", COMP EDUC, 36(4), 2000, pp. 397-416
17. Kitagawa, N; Goto, M; Kurozumi, K; Maruo, S; Fukayama, M; Naoe, T; Yasukawa, M; Hino, K; Suzuki, T; Todo, S; Takada, K
    Epstein-Barr virus-encoded poly(A)- RNA supports Burkitt's lymphoma growththrough interleukin-10 induction
    EMBO JOURNAL
    
    N. Kitagawa et al., "Epstein-Barr virus-encoded poly(A)- RNA supports Burkitt's lymphoma growththrough interleukin-10 induction", EMBO J, 19(24), 2000, pp. 6742-6750
18. Nakano, Y; Naoe, T; Kiyoi, H; Kunishima, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Saito, H; Ohno, R
    Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia
    LEUKEMIA RESEARCH
    
    Y. Nakano et al., "Poor clinical significance of p53 gene polymorphism in acute myeloid leukemia", LEUK RES, 24(4), 2000, pp. 349-352
19. Kitamura, K; Hoshi, S; Koike, M; Kiyoi, H; Saito, H; Naoe, T
    Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid
    BRITISH JOURNAL OF HAEMATOLOGY
    
    K. Kitamura et al., "Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-transretinoic acid", BR J HAEM, 108(4), 2000, pp. 696-702
20. Takeshita, A; Shinjo, K; Naito, K; Ohnishi, K; Sugimoto, Y; Yamakawa, Y; Tanimoto, M; Kitamura, K; Naoe, T; Ouno, R
    Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A. Takeshita et al., "Role of P-glycoprotein in all-trans retinoic acid (ATRA) resistance in acute promyelocytic leukaemia cells: analysis of intracellular concentration of ATRA", BR J HAEM, 108(1), 2000, pp. 90-92
21. Yoshida, M; Tsubaki, K; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Minami, S; Hiraoka, A; Takahashi, I; Naoe, T; Asou, N; Kageyama, S; Tomonaga, M; Saito, H; Ohno, R
    Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    M. Yoshida et al., "Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991", INT J HEMAT, 70(4), 1999, pp. 261-267
22. Miyawaki, S; Kobayashi, T; Tanimoto, M; Kuriyama, K; Murakami, H; Yoshida, M; Minami, S; Minato, K; Tsubaki, K; Omoto, E; Oh, H; Jinnai, I; Sakamaki, H; Hiraoka, A; Kanamura, A; Takahashi, I; Saito, K; Naoe, T; Yamada, O; Asou, N; Kageyama, S; Emi, N; Ueda, T; Tomonaga, M; Saito, H; Ueda, R; Ohno, R
    Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    S. Miyawaki et al., "Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy", INT J HEMAT, 70(1), 1999, pp. 56-57
23. Kosugi, H; Towatari, M; Hatano, S; Kitamura, K; Kiyoi, H; Kinoshita, T; Tanimoto, M; Murate, T; Kawashima, K; Saito, H; Naoe, T
    Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy
    LEUKEMIA
    
    H. Kosugi et al., "Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy", LEUKEMIA, 13(9), 1999, pp. 1316-1324
24. Kiyoi, H; Naoe, T
    Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells
    LEUKEMIA
    
    H. Kiyoi e T. Naoe, "Reply - Review of the immunoglobulin light chain variable region sequencesfrom multiple myeloma cells", LEUKEMIA, 13(5), 1999, pp. 829-830
25. Yanagi, M; Shinjo, K; Takeshita, A; Tobita, T; Yano, K; Kobayashi, M; Terasaki, H; Naoe, T; Ohnishi, K; Ohno, R
    Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells
    LEUKEMIA
    
    M. Yanagi et al., "Simple and reliably sensitive diagnosis and monitoring of Philadelphia chromosome-positive cells in chronic myeloid leukemia by interphase fluorescence in situ hybridization of peripheral blood cells", LEUKEMIA, 13(4), 1999, pp. 542-552
26. Iida, M; Towatari, M; Nakao, A; Iida, H; Kiyoi, H; Nakano, Y; Tanimoto, M; Saito, H; Naoe, T
    Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation
    LEUKEMIA
    
    M. Iida et al., "Lack of constitutive activation of MAP kinase pathway in human acute myeloid leukemia cells with N-Ras mutation", LEUKEMIA, 13(4), 1999, pp. 585-589
27. Mizuta, S; Ito, Y; Kohno, A; Kiyoi, H; Miyamura, K; Tanimoto, M; Takamatsu, J; Naoe, T; Morishima, Y; Ueda, R; Saito, H
    Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation
    BONE MARROW TRANSPLANTATION
    
    S. Mizuta et al., "Accurate quantitation of residual tumor burden at bone marrow harvest predicts timing of subsequent relapse in patients with common ALL treated by autologous bone marrow transplantation", BONE MAR TR, 24(7), 1999, pp. 777-784
28. Nakano, Y; Kiyoi, H; Miyawaki, S; Asou, N; Ohno, R; Saito, H; Naoe, T
    Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene
    BRITISH JOURNAL OF HAEMATOLOGY
    
    Y. Nakano et al., "Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene", BR J HAEM, 104(4), 1999, pp. 659-664
29. Naoe, T; Kitamura, K
    Relationship between degradation of PML-RAR alpha and differentiation
    BLOOD
    
    T. Naoe e K. Kitamura, "Relationship between degradation of PML-RAR alpha and differentiation", BLOOD, 94(4), 1999, pp. 1478-1478
30. Kiyoi, H; Naoe, T; Nakano, Y; Yokota, S; Minami, S; Miyawaki, S; Asou, N; Kuriyama, K; Jinnai, I; Shimazaki, C; Akiyama, H; Saito, K; Oh, H; Motoji, T; Omoto, E; Saito, H; Ohno, R; Ueda, R
    Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
    BLOOD
    
    H. Kiyoi et al., "Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia", BLOOD, 93(9), 1999, pp. 3074-3080
31. TAKAHASHI Y; HORIBE K; KIYOI H; MIYASHITA Y; FUKUDA M; MORI H; NOZAKI C; HASEGAWA S; KAWABE T; KATO K; KOJIMA S; MATUYAMA T; NAOE T
    PROGNOSTIC-SIGNIFICANCE OF TEL AML1 FUSION TRANSCRIPT IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA/
    Journal of pediatric hematology/oncology
    
    Y. Takahashi et al., "PROGNOSTIC-SIGNIFICANCE OF TEL AML1 FUSION TRANSCRIPT IN CHILDHOOD B-PRECURSOR ACUTE LYMPHOBLASTIC-LEUKEMIA/", Journal of pediatric hematology/oncology, 20(3), 1998, pp. 190-195
32. UEDA T; MIYAWAKI S; ASOU N; KURAISHI Y; HIRAOKA A; KURIYAMA K; MINAMI S; OHSHIMA T; INO T; TAMURA J; KANAMARU A; NISHIKAWA K; TANIMOTO M; OH H; SAITO K; NAGATA K; NAOE T; YAMADA O; URASAKI Y; SAKURA T; OHNO R
    RESPONSE-ORIENTED INDIVIDUALIZED INDUCTION THERAPY WITH 6 DRUGS FOLLOWED BY 4 COURSES OF INTENSIVE CONSOLIDATION, 1 YEAR MAINTENANCE AND INTENSIFICATION THERAPY - THE ALL90 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP
    International journal of hematology
    
    T. Ueda et al., "RESPONSE-ORIENTED INDIVIDUALIZED INDUCTION THERAPY WITH 6 DRUGS FOLLOWED BY 4 COURSES OF INTENSIVE CONSOLIDATION, 1 YEAR MAINTENANCE AND INTENSIFICATION THERAPY - THE ALL90 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP", International journal of hematology, 68(3), 1998, pp. 279-289
33. Tanimoto, M; Miyawaki, S; Ino, T; Kyo, T; Sakamaki, H; Naoe, T; Hiraoka, A; Asou, N; Ohshima, T; Tsubaki, K; Kuriyama, K; Ueda, T; Minamil, S; Okabe, K; Saito, H; Murakami, H; Hirano, M; Dohy, H; Onozawa, Y; Suzuki, H; Ohno, R
    Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
    INTERNATIONAL JOURNAL OF HEMATOLOGY
    
    M. Tanimoto et al., "Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)", INT J HEMAT, 68(4), 1998, pp. 421-429
34. IWANAGA M; KUNISHIMA S; IKEDA S; TOMONAGA M; NAOE T
    VULNERABLE MUTATION TRP126-]STOP OF GLYCOPROTEIN-IX IN JAPANESE BERNARD-SOULIER-SYNDROME
    European journal of haematology
    
    M. Iwanaga et al., "VULNERABLE MUTATION TRP126-]STOP OF GLYCOPROTEIN-IX IN JAPANESE BERNARD-SOULIER-SYNDROME", European journal of haematology, 60(4), 1998, pp. 264-266
35. KIYOI H; TOWATARI M; YOKOTA S; HAMAGUCHI M; OHNO R; SAITO H; NAOE T
    INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS A NOVEL MODALITY OF ELONGATION MUTATION WHICH CAUSES CONSTITUTIVE ACTIVATION OF THE PRODUCT
    Leukemia
    
    H. Kiyoi et al., "INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS A NOVEL MODALITY OF ELONGATION MUTATION WHICH CAUSES CONSTITUTIVE ACTIVATION OF THE PRODUCT", Leukemia, 12(9), 1998, pp. 1333-1337
36. KUDO K; YOSHIDA H; KIYOI H; NUMATA S; HORIBE K; NAOE T
    ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    K. Kudo et al., "ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 12(8), 1998, pp. 1171-1175
37. KIYOI H; NAITO K; OHNO R; SAITO H; NAOE T
    CHARACTERIZATION OF THE IMMUNOGLOBULIN LIGHT-CHAIN VARIABLE REGION GENE EXPRESSED IN MULTIPLE-MYELOMA
    Leukemia
    
    H. Kiyoi et al., "CHARACTERIZATION OF THE IMMUNOGLOBULIN LIGHT-CHAIN VARIABLE REGION GENE EXPRESSED IN MULTIPLE-MYELOMA", Leukemia, 12(4), 1998, pp. 601-609
38. YOSHIDA H; KONDO M; ICHIHASHI T; HASHIMOTO N; INAZAWA J; OHNO R; NAOE T
    A NOVEL MYELOID CELL-LINE, MARIMO, DERIVED FROM THERAPY-RELATED ACUTEMYELOID-LEUKEMIA DURING TREATMENT OF ESSENTIAL THROMBOCYTHEMIA - CONSISTENT CHROMOSOMAL-ABNORMALITIES AND TEMPORARY C-MYC GENE AMPLIFICATION
    Cancer genetics and cytogenetics
    
    H. Yoshida et al., "A NOVEL MYELOID CELL-LINE, MARIMO, DERIVED FROM THERAPY-RELATED ACUTEMYELOID-LEUKEMIA DURING TREATMENT OF ESSENTIAL THROMBOCYTHEMIA - CONSISTENT CHROMOSOMAL-ABNORMALITIES AND TEMPORARY C-MYC GENE AMPLIFICATION", Cancer genetics and cytogenetics, 100(1), 1998, pp. 21-24
39. OHNISHI K; TOMONAGA M; KAMADA N; ONOZAWA K; KURAMOTO A; DOHY H; MIZOGUCHI H; MIYAWAKI S; TSUBAKI K; MIURA Y; OMINE M; KOBAYASHI T; NAOE T; OHSHIMA T; HIRASHIMA K; OHTAKE S; TAKAHASHI I; MORISHIMA Y; NAITO K; ASOU N; TANIMOTO M; SAKUMA A; OHNO R
    A LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR CHRONIC MYELOGENOUS LEUKEMIA
    Leukemia research
    
    K. Ohnishi et al., "A LONG-TERM FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR CHRONIC MYELOGENOUS LEUKEMIA", Leukemia research, 22(9), 1998, pp. 779-786
40. AKAO Y; MIZOGUCHI H; KOJIMA S; NAOE T; OHISHI N; YAGI K
    ARSENIC INDUCES APOPTOSIS IN B-CELL LEUKEMIC-CELL LINES IN-VITRO - ACTIVATION OF CASPASES AND DOWN-REGULATION OF BCL-2 PROTEIN
    British Journal of Haematology
    
    Y. Akao et al., "ARSENIC INDUCES APOPTOSIS IN B-CELL LEUKEMIC-CELL LINES IN-VITRO - ACTIVATION OF CASPASES AND DOWN-REGULATION OF BCL-2 PROTEIN", British Journal of Haematology, 102(4), 1998, pp. 1055-1060
41. HAYAKAWA F; TOWATARI M; IIDA H; WAKAO H; KIYOI H; NAOE T; SAITO H
    DIFFERENTIAL CONSTITUTIVE ACTIVATION BETWEEN STAT-RELATED PROTEINS AND MAP KINASE IN PRIMARY ACUTE MYELOGENOUS LEUKEMIA
    British Journal of Haematology
    
    F. Hayakawa et al., "DIFFERENTIAL CONSTITUTIVE ACTIVATION BETWEEN STAT-RELATED PROTEINS AND MAP KINASE IN PRIMARY ACUTE MYELOGENOUS LEUKEMIA", British Journal of Haematology, 101(3), 1998, pp. 521-528
42. KUNISHIMA S; MIZUNO S; NAOE T; SAITO H; KAMIYA T
    GENES FOR THROMBOPOIETIN AND C-MPL ARE NOT RESPONSIBLE FOR FAMILIAL THROMBOCYTHEMIA - A CASE-STUDY
    British Journal of Haematology
    
    S. Kunishima et al., "GENES FOR THROMBOPOIETIN AND C-MPL ARE NOT RESPONSIBLE FOR FAMILIAL THROMBOCYTHEMIA - A CASE-STUDY", British Journal of Haematology, 100(2), 1998, pp. 383-386
43. MAKISHIMA M; UMESONO K; SHUDO K; NAOE T; KISHI K; HONMA Y
    INDUCTION OF DIFFERENTIATION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS BY9-CIS RETINOIC ACID ALPHA-TOCOPHEROL ESTER (9-CIS TRETINOIN TOCOFERIL)
    Blood
    
    M. Makishima et al., "INDUCTION OF DIFFERENTIATION IN ACUTE PROMYELOCYTIC LEUKEMIA-CELLS BY9-CIS RETINOIC ACID ALPHA-TOCOPHEROL ESTER (9-CIS TRETINOIN TOCOFERIL)", Blood, 91(12), 1998, pp. 4715-4726
44. KUNISHIMA S; HEATON DC; NAOE T; HICKTON C; MIZUNO S; SAITO H; KAMIYA T
    DE-NOVO MUTATION OF THE PLATELET GLYCOPROTEIN IB-ALPHA GENE IN A PATIENT WITH PSEUDO-VON-WILLEBRAND-DISEASE
    Blood coagulation & fibrinolysis
    
    S. Kunishima et al., "DE-NOVO MUTATION OF THE PLATELET GLYCOPROTEIN IB-ALPHA GENE IN A PATIENT WITH PSEUDO-VON-WILLEBRAND-DISEASE", Blood coagulation & fibrinolysis, 8(5), 1997, pp. 311-315
45. YUASA H; HAMAJIMA N; UEDA R; OHNO R; ASOU N; UTSUNOMIYA A; OGURA M; TAKIGAWA N; UEDA T; HIRAOKA A; MATSUDA S; KURAISHI Y; NISHIKAWA K; UIKE N; TAKESHITA A; TAKEMOTO Y; SHIMAZAKI C; SAKAMAKI H; INO T; MATSUSHIMA T; KURIYAMA K; HIRAI H; NAOE T; TSUBAKI K; TAKAHASHI M; TAKEYAMA K; MORISHIMA Y; ITOH K; OMOTO E; HODOHARA K; TAKAHASHI I
    CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE
    International journal of hematology
    
    H. Yuasa et al., "CASE-CONTROL STUDY OF LEUKEMIA AND DIAGNOSTIC RADIATION EXPOSURE", International journal of hematology, 65(3), 1997, pp. 251-261
46. KITAMURA K; YOSHIDA H; OHNO R; NAOE T
    TOXIC EFFECTS OF ARSENIC (AS3-IONS ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS() AND OTHER METAL)
    International journal of hematology
    
    K. Kitamura et al., "TOXIC EFFECTS OF ARSENIC (AS3-IONS ON ACUTE PROMYELOCYTIC LEUKEMIA-CELLS() AND OTHER METAL)", International journal of hematology, 65(2), 1997, pp. 179-185
47. KIYOI H; NAOE T; YOKOTA S; NAKAO M; MINAMI S; KURIYAMA K; TAKESHITA A; SAITO K; HASEGAWA S; SHIMODAIRA S; TAMURA J; SHIMAZAKI C; MATSUE K; KOBAYASHI H; ARIMA N; SUZUKI R; MORISHITA H; SAITO H; UEDA R; OHNO R
    INTERNAL TANDEM DUPLICATION OF FLT3 ASSOCIATED WITH LEUKOCYTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    H. Kiyoi et al., "INTERNAL TANDEM DUPLICATION OF FLT3 ASSOCIATED WITH LEUKOCYTOSIS IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 11(9), 1997, pp. 1447-1452
48. MORI H; KIYOI H; HORIBE K; OHNO R; NAOE T
    COMPARISON OF THE IMMUNOGLOBULIN GENE TRANSCRIPTS BETWEEN IMMATURE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AND THE NORMAL PHENOTYPIC COUNTERPARTS IN THE BONE-MARROW
    Leukemia
    
    H. Mori et al., "COMPARISON OF THE IMMUNOGLOBULIN GENE TRANSCRIPTS BETWEEN IMMATURE B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA AND THE NORMAL PHENOTYPIC COUNTERPARTS IN THE BONE-MARROW", Leukemia, 11(8), 1997, pp. 1274-1280
49. KITAMURA K; KIYOI H; YOSHIDA H; SAITO H; OHNO R; NAOE T
    MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    K. Kitamura et al., "MUTANT AF-2 DOMAIN OF PML-RAR-ALPHA IN RETINOIC ACID-RESISTANT NB4 CELLS - DIFFERENTIATION-INDUCED BY RA IS TRIGGERED DIRECTLY THROUGH PML-RAR-ALPHA AND ITS DOWN-REGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 11(11), 1997, pp. 1950-1956
50. YOKOTA S; KIYOI H; NAKAO M; IWAI T; MISAWA S; OKUDA T; SONODA Y; ABE T; KAHSIMA K; MATSUO Y; NAOE T
    INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS PREFERENTIALLY SEEN IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME AMONG VARIOUS HEMATOLOGICAL MALIGNANCIES - A STUDY ON A LARGE SERIES OF PATIENTS AND CELL-LINES
    Leukemia
    
    S. Yokota et al., "INTERNAL TANDEM DUPLICATION OF THE FLT3 GENE IS PREFERENTIALLY SEEN IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME AMONG VARIOUS HEMATOLOGICAL MALIGNANCIES - A STUDY ON A LARGE SERIES OF PATIENTS AND CELL-LINES", Leukemia, 11(10), 1997, pp. 1605-1609
51. KITAMURA K; KIYOI H; YOSHIDA H; TOBITA T; TAKESHITA A; OHNO R; NAOE T
    NEW RETINOIDS AND ARSENIC COMPOUNDS FOR THE TREATMENT OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND BASIC STUDIES FOR THE NEXT-GENERATION
    Cancer chemotherapy and pharmacology
    
    K. Kitamura et al., "NEW RETINOIDS AND ARSENIC COMPOUNDS FOR THE TREATMENT OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA - CLINICAL AND BASIC STUDIES FOR THE NEXT-GENERATION", Cancer chemotherapy and pharmacology, 40, 1997, pp. 36-41
52. YAMANAKA K; KUBO K; KIYOI H; ICHIHASHI T; KATO K; HORIBE K; NAOE T
    UNUSUAL FEATURE OF THE T-CELL RECEPTOR GENES IN T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    Leukemia research
    
    K. Yamanaka et al., "UNUSUAL FEATURE OF THE T-CELL RECEPTOR GENES IN T-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA", Leukemia research, 21(7), 1997, pp. 667-674
53. NOZAKI N; NAOE T; OKAZAKI T
    IMMUNOAFFINITY PURIFICATION AND CHARACTERIZATION OF CACGTG SEQUENCE-BINDING PROTEINS FROM CULTURED-MAMMALIAN-CELLS USING AN ANTI C-MYC MONOCLONAL-ANTIBODY RECOGNIZING THE DNA-BINDING DOMAIN
    Journal of Biochemistry
    
    N. Nozaki et al., "IMMUNOAFFINITY PURIFICATION AND CHARACTERIZATION OF CACGTG SEQUENCE-BINDING PROTEINS FROM CULTURED-MAMMALIAN-CELLS USING AN ANTI C-MYC MONOCLONAL-ANTIBODY RECOGNIZING THE DNA-BINDING DOMAIN", Journal of Biochemistry, 121(3), 1997, pp. 550-559
54. MATSUI T; KUNISHIMA S; HAMAKO J; KATAYAMA M; KAMIYA T; NAOE T; OZEKI Y; FUJIMURA Y; TITANI K
    INTERACTION OF VON-WILLEBRAND-FACTOR WITH THE EXTRACELLULAR-MATRIX AND GLYCOCALICIN UNDER STATIC CONDITIONS
    Journal of Biochemistry
    
    T. Matsui et al., "INTERACTION OF VON-WILLEBRAND-FACTOR WITH THE EXTRACELLULAR-MATRIX AND GLYCOCALICIN UNDER STATIC CONDITIONS", Journal of Biochemistry, 121(2), 1997, pp. 376-381
55. TOBITA T; TAKESHITA A; KITAMURA K; OHNISHI K; YANAGI M; HIRAOKA A; KARASUNO T; TAKEUCHI M; MIYAWAKI S; UEDA R; NAOE T; OHNO R
    TREATMENT WITH A NEW SYNTHETIC RETINOID, AM80, OF ACUTE PROMYELOCYTICLEUKEMIA RELAPSED FROM COMPLETE REMISSION INDUCED BY ALL-TRANS-RETINOIC ACID
    Blood
    
    T. Tobita et al., "TREATMENT WITH A NEW SYNTHETIC RETINOID, AM80, OF ACUTE PROMYELOCYTICLEUKEMIA RELAPSED FROM COMPLETE REMISSION INDUCED BY ALL-TRANS-RETINOIC ACID", Blood, 90(3), 1997, pp. 967-973
56. KUDO K; YOSHIDA H; KIYOI H; HORIBE K; NAOE T; MURATE T
    CLUSTERED BREAKPOINTS OF T(15-17) IN ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA PRECEDED BY LANGERHANS CELL HISTIOCYTOSIS
    Blood
    
    K. Kudo et al., "CLUSTERED BREAKPOINTS OF T(15-17) IN ETOPOSIDE-RELATED ACUTE PROMYELOCYTIC LEUKEMIA PRECEDED BY LANGERHANS CELL HISTIOCYTOSIS", Blood, 90(10), 1997, pp. 3575-3575
57. CHEN GQ; SHI XG; TANG W; XIONG SM; ZHU J; CAI X; HAN ZG; NI JH; SHI GY; JIA PM; LIU MM; HE KL; NIU C; MA J; ZHANG P; ZHANG TD; PAUL P; NAOE T; KITAMURA K; MILLER W; WAXMAN S; WANG ZY; DETHE H; CHEN SJ; CHEN Z
    USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS
    Blood
    
    G.Q. Chen et al., "USE OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) .1. AS2O3 EXERTS DOSE-DEPENDENT DUAL EFFECTS ON APL CELLS", Blood, 89(9), 1997, pp. 3345-3353
58. KUNISHIMA S; LOPEZ JA; KOBAYASHI S; IMAI N; KAMIYA T; SAITO H; NAOE T
    MISSENSE MUTATIONS OF THE GLYCOPROTEIN (GP) IB-BETA GENE IMPAIRING THE GPIB ALPHA BETA DISULFIDE LINKAGE IN A FAMILY WITH GIANT PLATELET DISORDER/
    Blood
    
    S. Kunishima et al., "MISSENSE MUTATIONS OF THE GLYCOPROTEIN (GP) IB-BETA GENE IMPAIRING THE GPIB ALPHA BETA DISULFIDE LINKAGE IN A FAMILY WITH GIANT PLATELET DISORDER/", Blood, 89(7), 1997, pp. 2404-2412
59. KAGAMI Y; ARIYOSHI Y; HORIUCHI A; KANAMARU A; KANO Y; NAOE T; OGURO M; OHNO R; SAMPI K; SHIRAKAWA S; MASAOKA T; FURUE H
    FEASIBILITY OF SALVAGE CHEMOTHERAPY FOR REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA WITH 2 TOPOISOMERASE-II INHIBITORS, MST-16 AND VP-16
    International journal of hematology
    
    Y. Kagami et al., "FEASIBILITY OF SALVAGE CHEMOTHERAPY FOR REFRACTORY OR RELAPSED NON-HODGKINS-LYMPHOMA WITH 2 TOPOISOMERASE-II INHIBITORS, MST-16 AND VP-16", International journal of hematology, 64(3-4), 1996, pp. 221-229
60. KUNISHIMA S; TAHARA T; KATO T; KOBAYASHI S; SAITO H; NAOE T
    SERUM THROMBOPOIETIN AND PLASMA GLYCOCALICIN CONCENTRATIONS AS USEFULDIAGNOSTIC MARKERS IN THROMBOCYTOPENIC DISORDERS
    European journal of haematology
    
    S. Kunishima et al., "SERUM THROMBOPOIETIN AND PLASMA GLYCOCALICIN CONCENTRATIONS AS USEFULDIAGNOSTIC MARKERS IN THROMBOCYTOPENIC DISORDERS", European journal of haematology, 57(1), 1996, pp. 68-71
61. KUNISHIMA S; KOBAYASHI S; NAOE T
    INCREASED BUT HIGHLY DISPERSED LEVELS OF PLASMA GLYCOCALICIN IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION
    European journal of haematology
    
    S. Kunishima et al., "INCREASED BUT HIGHLY DISPERSED LEVELS OF PLASMA GLYCOCALICIN IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION", European journal of haematology, 56(3), 1996, pp. 173-177
62. KIYOI H; NAITO K; OHNO R; NAOE T
    COMPARABLE GENE STRUCTURE OF THE IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION BETWEEN MULTIPLE-MYELOMA AND NORMAL BONE-MARROW LYMPHOCYTES
    Leukemia
    
    H. Kiyoi et al., "COMPARABLE GENE STRUCTURE OF THE IMMUNOGLOBULIN HEAVY-CHAIN VARIABLE REGION BETWEEN MULTIPLE-MYELOMA AND NORMAL BONE-MARROW LYMPHOCYTES", Leukemia, 10(11), 1996, pp. 1804-1812
63. KOBAYASHI T; MIYAWAKI S; TANIMOTO M; KURIYAMA K; MURAKAMI H; YOSHIDA M; MINAMI S; MINATO K; TSUBAKI K; OHMOTO E; OH H; JINNAI I; SAKAMAKI H; HIRAOKA A; KANAMARU A; TAKAHASHI I; SAITO K; NAOE T; YAMADA O; ASOU N; KAGEYAMA S; EMI N; MATSUOKA A; TOMONAGA M; SAITO H; UEDA R; OHNO R
    RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA
    Journal of clinical oncology
    
    T. Kobayashi et al., "RANDOMIZED TRIALS BETWEEN BEHENOYL CYTARABINE AND CYTARABINE IN COMBINATION INDUCTION AND CONSOLIDATION THERAPY, AND WITH OR WITHOUT UBENIMEX AFTER MAINTENANCE INTENSIFICATION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA", Journal of clinical oncology, 14(1), 1996, pp. 204-213
64. TAMURA K; MIYAZAKI T; SAKURADA K; KASAI M; KAWAMURA K; YOSHIDA Y; SAKATA Y; TAKAMI H; UZUKA Y; SAITOU Y; HATTORI M; SANPI K; TAKAGI T; SAKAI T; OGAWA M; MIZUNUMA N; KURAISHI Y; KOBAYASHI S; TOYAMA K; KIMURA Y; MIZOGUCHI H; HOSHINO S; OHSHIMA T; TAKEUCHI H; FUJITA H; SAITO H; OHNO R; YAMADA K; NAOE T; KIMURA K; INAGAKI J; HIRANO M; EZAKI K; OKAMOTO M; SHIRAKAWA S; KOBAYASHI T; MASAOKA T; SHIBATA H; NAKAMURA T; FUKUSHIMA T; KUMURA I; TAKAHASHI I; TOKI H; OKABE K; KURAMOTO A; MAEHAMA S; ICHIMARU M; MORIUCHI Y; MASUMOTO M; MATSUMOTO T
    A PHASE-I STUDY OF IDARUBICIN HYDROCHLORIDE IN PATIENTS WITH ACUTE-LEUKEMIA
    Seminars in hematology
    
    K. Tamura et al., "A PHASE-I STUDY OF IDARUBICIN HYDROCHLORIDE IN PATIENTS WITH ACUTE-LEUKEMIA", Seminars in hematology, 33(4), 1996, pp. 2-11
65. KIYOI H; MORI H; HORIBE K; OHNO R; NAOE T
    COMPARISON OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION-3 STRUCTURE AMONG THE DNA-SEQUENCES AND THE MU-TRANSCRIPT AND GAMMA-TRANSCRIPT IN HUMAN B-LINEAGE CELLS
    Immunology
    
    H. Kiyoi et al., "COMPARISON OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION-3 STRUCTURE AMONG THE DNA-SEQUENCES AND THE MU-TRANSCRIPT AND GAMMA-TRANSCRIPT IN HUMAN B-LINEAGE CELLS", Immunology, 89(3), 1996, pp. 324-330
66. YOSHIDA H; KITAMURA K; TANAKA K; OMURA S; MIYAZAKI T; HACHIYA T; OHNO R; NAOE T
    ACCELERATED DEGRADATION OF PML-RETINOIC ACID RECEPTOR-ALPHA (PML-RARA) ONCOPROTEIN BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - POSSIBLE ROLE OF THE PROTEASOME PATHWAY
    Cancer research
    
    H. Yoshida et al., "ACCELERATED DEGRADATION OF PML-RETINOIC ACID RECEPTOR-ALPHA (PML-RARA) ONCOPROTEIN BY ALL-TRANS-RETINOIC ACID IN ACUTE PROMYELOCYTIC LEUKEMIA - POSSIBLE ROLE OF THE PROTEASOME PATHWAY", Cancer research, 56(13), 1996, pp. 2945-2948
67. MARUKAWA O; AKAO Y; INAZAWA J; ARIYAMA T; ABE T; NAOE T; TANIMOTO M; SAITO H; OTSUKI Y; TSUJIMOTO Y
    MOLECULAR-CLONING OF THE BREAKPOINT OF T(11-22)(Q23-Q11) CHROMOSOME-TRANSLOCATION IN AN ADULT ACUTE MYELOMONOCYTIC LEUKEMIA
    British Journal of Haematology
    
    O. Marukawa et al., "MOLECULAR-CLONING OF THE BREAKPOINT OF T(11-22)(Q23-Q11) CHROMOSOME-TRANSLOCATION IN AN ADULT ACUTE MYELOMONOCYTIC LEUKEMIA", British Journal of Haematology, 92(3), 1996, pp. 687-691
68. CHEN GQ; ZHU J; SHI XG; NI JH; ZHONG HJ; SI GY; JIN XL; TANG W; LI XS; XONG SM; SHEN ZX; SUN GL; MA J; ZHANG P; ZHANG TD; GAZIN C; NAOE T; CHEN SJ; WANG ZY; CHEN Z
    IN-VITRO STUDIES ON CELLULAR AND MOLECULAR MECHANISMS OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA - AS2O3 INDUCES NB4 CELL APOPTOSIS WITH DOWN-REGULATION OF BCL-2 EXPRESSION AND MODULATION OF PML-RAR-ALPHA PML PROTEINS/
    Blood
    
    G.Q. Chen et al., "IN-VITRO STUDIES ON CELLULAR AND MOLECULAR MECHANISMS OF ARSENIC TRIOXIDE (AS2O3) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA - AS2O3 INDUCES NB4 CELL APOPTOSIS WITH DOWN-REGULATION OF BCL-2 EXPRESSION AND MODULATION OF PML-RAR-ALPHA PML PROTEINS/", Blood, 88(3), 1996, pp. 1052-1061
69. KUBO K; YAMANAKA K; KIYOI H; FUKUTANI H; ITO M; HAYAKAWA R; OHNO R; NAOE T
    DIFFERENT T-CELL RECEPTOR REPERTOIRES BETWEEN LESIONS AND PERIPHERAL-BLOOD IN ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    Blood
    
    K. Kubo et al., "DIFFERENT T-CELL RECEPTOR REPERTOIRES BETWEEN LESIONS AND PERIPHERAL-BLOOD IN ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION", Blood, 87(7), 1996, pp. 3019-3026
70. ICHIHASHI T; NAOE T; OHNO R
    ATLAS OF BLOOD-DISEASE ON THE INTERNET
    Blood
    
    T. Ichihashi et al., "ATLAS OF BLOOD-DISEASE ON THE INTERNET", Blood, 87(1), 1996, pp. 417-418
71. YOSHIDA H; NAOE T; FUKUTANI H; KIYOI H; KUBO K; OHNO R
    ANALYSIS OF THE JOINING SEQUENCES OF THE T(15-17) TRANSLOCATION IN HUMAN ACUTE PROMYELOCYTIC LEUKEMIA - SEQUENCE NONSPECIFIC RECOMBINATION BETWEEN THE PML AND RARA GENES WITHIN IDENTICAL SHORT STRETCHES
    Genes, chromosomes & cancer
    
    H. Yoshida et al., "ANALYSIS OF THE JOINING SEQUENCES OF THE T(15-17) TRANSLOCATION IN HUMAN ACUTE PROMYELOCYTIC LEUKEMIA - SEQUENCE NONSPECIFIC RECOMBINATION BETWEEN THE PML AND RARA GENES WITHIN IDENTICAL SHORT STRETCHES", Genes, chromosomes & cancer, 12(1), 1995, pp. 37-44
72. FUKUTANI H; NAOE T; OHNO R; YOSHIDA H; MIYAWAKI S; SHIMAZAKI C; MIYAKE T; NAKAYAMA Y; KOBAYASHI H; GOTO S; TAKESHITA A; KOBAYASHI S; KATO Y; SHIRAISHI K; SASADA M; OHTAKE S; MURAKAMI H; KOBAYASHI M; ENDO N; SHINDO H; MATSUSHITA K; HASEGAWA S; TSUJI K; UEDA Y; TOMINAGA N; FURUYA H; INOUE Y; TAKEUCHI J; MORISHITA H; IIDA H
    ISOFORMS OF PML-RETINOIC ACID RECEPTOR-ALPHA FUSED TRANSCRIPTS AFFECTNEITHER CLINICAL-FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA NOR PROGNOSIS AFTER TREATMENT WITH ALL-TRANS-RETINOIC ACID
    Leukemia
    
    H. Fukutani et al., "ISOFORMS OF PML-RETINOIC ACID RECEPTOR-ALPHA FUSED TRANSCRIPTS AFFECTNEITHER CLINICAL-FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA NOR PROGNOSIS AFTER TREATMENT WITH ALL-TRANS-RETINOIC ACID", Leukemia, 9(9), 1995, pp. 1478-1482
73. NAOE T; YOSHIDA H; KITAMURA K; CHINO M; OSUMI K; OHNO R
    DELAYED OR INSUFFICIENT RESTORATION OF PML AND PML-RAR-ALPHA SUBCELLULAR-LOCALIZATION AFTER EXPOSURE IN-VITRO TO RETINOIC ACIDS IN ALL-TRANS-RETINOIC ACID-RESISTANT APL CELLS
    Leukemia
    
    T. Naoe et al., "DELAYED OR INSUFFICIENT RESTORATION OF PML AND PML-RAR-ALPHA SUBCELLULAR-LOCALIZATION AFTER EXPOSURE IN-VITRO TO RETINOIC ACIDS IN ALL-TRANS-RETINOIC ACID-RESISTANT APL CELLS", Leukemia, 9(9), 1995, pp. 1610-1611
74. FUKUTANI H; NAOE T; OHNO R; YOSHIDA H; KIYOI H; MIYAWAKI S; MORISHITA H; SANO F; KAMIBAYASHI H; MATSUE K; MIYAKE T; HASEGAWA S; UEDA Y; KATO Y; KOBAYASHI H; SHIMAZAKI C; KOBAYASHI M; KURANE R; SAKOTA H; MASAKI K; WAKAYAMA T; TOHYAMA K; NONAKA Y; NATORI H
    PROGNOSTIC-SIGNIFICANCE OF THE RT-PCR ASSAY OF PML-RARA TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    H. Fukutani et al., "PROGNOSTIC-SIGNIFICANCE OF THE RT-PCR ASSAY OF PML-RARA TRANSCRIPTS IN ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 9(4), 1995, pp. 588-593
75. KIYOI H; FUKUTANI H; YAMAUCHI T; KUBO K; OHNO R; YAMAMORI S; NAOE T
    CONTINUING IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS IN CHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISES AFTER BONE-MARROW TRANSPLANTATION
    Leukemia
    
    H. Kiyoi et al., "CONTINUING IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS IN CHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISES AFTER BONE-MARROW TRANSPLANTATION", Leukemia, 9(2), 1995, pp. 265-270
76. ZHU J; SHI XG; CHU HY; TONG JH; WANG ZY; NAOE T; WAXMAN S; CHEN SJ; CHEN Z
    EFFECT OF RETINOIC ACID ISOMERS ON PROLIFERATION, DIFFERENTIATION ANDPML RELOCALIZATION IN THE APL CELL-LINE NB4
    Leukemia
    
    J. Zhu et al., "EFFECT OF RETINOIC ACID ISOMERS ON PROLIFERATION, DIFFERENTIATION ANDPML RELOCALIZATION IN THE APL CELL-LINE NB4", Leukemia, 9(2), 1995, pp. 302-309
77. KIYOI H; KOJIMA S; KATO K; MATSUYAMA T; KODERA Y; OHNO R; NAOE T
    DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHILDHOOD COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH EX-VIVO PURGING AND SYSTEMIC IL-2 INFUSION - UNSUCCESSFUL PREDICTION OF SUBSEQUENT RELAPSE
    Bone marrow transplantation
    
    H. Kiyoi et al., "DETECTION OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH CHILDHOOD COMMON ACUTE LYMPHOBLASTIC-LEUKEMIA AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH EX-VIVO PURGING AND SYSTEMIC IL-2 INFUSION - UNSUCCESSFUL PREDICTION OF SUBSEQUENT RELAPSE", Bone marrow transplantation, 16(3), 1995, pp. 437-442
78. HIRABAYASHI N; KODERA Y; MATSUYAMA T; TANIMOTO M; HORIBE K; NAOE T; KOJIMA H; YAMADA H; UTSUMI M; MORISHIMA Y; MORISHITA Y; YAZAKI M; YOKOMAKU S; GOTO S; MINAMI S; KOJIMA S; SAITO H
    BONE-MARROW TRANSPLANTATION IN 614 PATIENTS - 20-YEAR EXPERIENCE OF THE NAGOYA-BONE-MARROW-TRANSPLANTATION-GROUP (NBMTG)
    Transplantation proceedings
    
    N. Hirabayashi et al., "BONE-MARROW TRANSPLANTATION IN 614 PATIENTS - 20-YEAR EXPERIENCE OF THE NAGOYA-BONE-MARROW-TRANSPLANTATION-GROUP (NBMTG)", Transplantation proceedings, 27(1), 1995, pp. 1380-1382
79. KIYOI H; NAITO K; OHNO R; NAOE T
    COMPARABLE PROFILES OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION (CDR)-3 IN CD5(-) HUMAN CORD-BLOOD B-LYMPHOCYTES()AND CD5()
    Immunology
    
    H. Kiyoi et al., "COMPARABLE PROFILES OF THE IMMUNOGLOBULIN HEAVY-CHAIN COMPLEMENTARITY-DETERMINING REGION (CDR)-3 IN CD5(-) HUMAN CORD-BLOOD B-LYMPHOCYTES()AND CD5()", Immunology, 85(2), 1995, pp. 236-240
80. OHNISHI K; OHNO R; TOMONAGA M; KAMADA N; ONOZAWA K; KURAMOTO A; DOHY H; MIZOGUCHI H; MIYAWAKI S; TSUBAKI K; MIURA Y; OMINE M; KOBAYASHI T; NAOE T; OHSHIMA T; HIRASHIMA K; OHTAKE S; TAKAHASHI I; MORISHIMA Y; NAITO K; ASOU N; TANIMOTO M; SAKUMA A; YAMADA K
    A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR NEWLY-DIAGNOSED CHROMIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
    Blood
    
    K. Ohnishi et al., "A RANDOMIZED TRIAL COMPARING INTERFERON-ALPHA WITH BUSULFAN FOR NEWLY-DIAGNOSED CHROMIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE", Blood, 86(3), 1995, pp. 906-916
81. NAOE T; KUDO K; YOSHIDA H; HORIBE K; OHNO R
    MOLECULAR ANALYSIS OF THE T(15-17) TRANSLOCATION IN DE-NOVO AND SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
    Blood
    
    T. Naoe et al., "MOLECULAR ANALYSIS OF THE T(15-17) TRANSLOCATION IN DE-NOVO AND SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA", Blood, 86(10), 1995, pp. 2933-2933
82. KUNISHIMA S; KOBAYASHI S; IMAI N; LOPEZ JA; SAITO H; NAOE T
    COMPOUND HETEROZYGOSITY FOR MISSENSE MUTATIONS IN THE GLYCOPROTEIN IB-BETA GENE ASSOCIATED WITH HEREDITARY GIANT PLATELET DISORDER
    Blood
    
    S. Kunishima et al., "COMPOUND HETEROZYGOSITY FOR MISSENSE MUTATIONS IN THE GLYCOPROTEIN IB-BETA GENE ASSOCIATED WITH HEREDITARY GIANT PLATELET DISORDER", Blood, 86(10), 1995, pp. 3592-3592
83. KIYOI H; FUKUTANI H; KUBO K; OHNO R; NAOE T
    CHARACTERIZATION OF IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS INCHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISIS FOLLOWING BONE-MARROW TRANSPLANTATION
    Internal medicine
    
    H. Kiyoi et al., "CHARACTERIZATION OF IMMUNOGLOBULIN HEAVY-CHAIN GENE REARRANGEMENTS INCHRONIC MYELOID-LEUKEMIA WITH RECURRENT B-LYMPHOID BLAST CRISIS FOLLOWING BONE-MARROW TRANSPLANTATION", Internal medicine, 33(12), 1994, pp. 786-789
84. OHNO R; OHNISHI K; TAKESHITA A; TANIMOTO M; MURAKAMI H; KANAMARU A; ASOU N; KOBAYASHI T; KURIYAMA K; OHMOTO E; SAKAMAKI H; TSUBAKI K; HIRAOKA A; YAMADA O; OH H; FURUSAWA S; MATSUDA S; NAOE T
    ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN
    Leukemia
    
    R. Ohno et al., "ALL-TRANS-RETINOIC ACID THERAPY IN RELAPSED REFRACTORY OR NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA (APL) IN JAPAN", Leukemia, 8, 1994, pp. 64-69
85. KUNISHIMA S; HATTORI M; KOBAYASHI S; HATTORI H; IWAMA Y; IMAI Y; OGAWA K; NAOE T; OHNO R
    ACTIVATION AND DESTRUCTION OF PLATELETS IN PATIENTS WITH RHEUMATIC HEART-DISEASE
    European heart journal
    
    S. Kunishima et al., "ACTIVATION AND DESTRUCTION OF PLATELETS IN PATIENTS WITH RHEUMATIC HEART-DISEASE", European heart journal, 15(3), 1994, pp. 335-338
86. KOBAYASHI T; MIYAWAKI S; TANIMOTO M; KURIYAMA K; MURAKAMI H; YOSHIDA M; KODERA Y; MINATO K; TSUBAKI K; OHMOTO E; OH H; JINNAI I; SAKAMAKI H; HIRAOKA A; KANAMARU A; TAKAHASHI I; FURUSAWA S; NAOE T; YAMADA O; ASOU N; NISHIKAWA K; OKABE K; OGURA M; TANAKA M; OHNO R
    RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS
    Blood
    
    T. Kobayashi et al., "RANDOMIZED TRIAL BETWEEN BEHENOYL CYTARABINE (BHAC) OR CYTARABINE IN COMBINATION CHEMOTHERAPY OF ADULT ACUTE MYELOID-LEUKEMIA (AML) (JALSG-AML89 PROTOCOL) AND ANALYSIS OF PROGNOSTIC FACTORS", Blood, 84(10), 1994, pp. 10000146-10000146
87. KUNISHIMA S; MIURA H; FUKUTANI H; YOSHIDA H; OSUMI K; KOBAYASHI S; OHNO R; NAOE T
    BERNARD-SOULIER-SYNDROME KAGOSHIMA - SER-444-]STOP MUTATION OF GLYCOPROTEIN (GP) IB-ALPHA RESULTING IN CIRCULATING TRUNCATED GPIB-ALPHA ANDSURFACE EXPRESSION OF GPIB-BETA AND GPIX
    Blood
    
    S. Kunishima et al., "BERNARD-SOULIER-SYNDROME KAGOSHIMA - SER-444-]STOP MUTATION OF GLYCOPROTEIN (GP) IB-ALPHA RESULTING IN CIRCULATING TRUNCATED GPIB-ALPHA ANDSURFACE EXPRESSION OF GPIB-BETA AND GPIX", Blood, 84(10), 1994, pp. 3356-3362
88. OHNO R; NAOE T; KANAMARU A; YOSHIDA M; HIRAOKA A; KOBAYASHI T; UEDA T; MINAMI S; MORISHIMA Y; SAITO Y; FURUSAWA S; IMAI K; TAKEMOTO Y; MIURA Y; TESHIMA H; HAMAJIMA N
    A DOUBLE-BLIND CONTROLLED-STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR STARTED 2 DAYS BEFORE INDUCTION CHEMOTHERAPY IN REFRACTORY ACUTE MYELOID-LEUKEMIA
    Blood
    
    R. Ohno et al., "A DOUBLE-BLIND CONTROLLED-STUDY OF GRANULOCYTE-COLONY-STIMULATING FACTOR STARTED 2 DAYS BEFORE INDUCTION CHEMOTHERAPY IN REFRACTORY ACUTE MYELOID-LEUKEMIA", Blood, 83(8), 1994, pp. 2086-2092
89. SHIMIZU N; NAOE T; KAWAZOE Y; SAKAGAMI H; NAKASHIMA H; MURAKAMI T; YAMAMOTO N
    LIGNIFIED MATERIALS AS MEDICINAL RESOURCES .6. ANTI-HIV ACTIVITY OF DEHYDROGENATION POLYMER OF P-COUMARIC ACID, A SYNTHETIC LIGNIN, IN A QUASI-INVIVO ASSAY SYSTEM AS AN INTERMEDIARY STEP TO CLINICAL-TRIALS
    Biological & pharmaceutical bulletin
    
    N. Shimizu et al., "LIGNIFIED MATERIALS AS MEDICINAL RESOURCES .6. ANTI-HIV ACTIVITY OF DEHYDROGENATION POLYMER OF P-COUMARIC ACID, A SYNTHETIC LIGNIN, IN A QUASI-INVIVO ASSAY SYSTEM AS AN INTERMEDIARY STEP TO CLINICAL-TRIALS", Biological & pharmaceutical bulletin, 16(4), 1993, pp. 434-436
90. KUBO K; NAOE T; KIYOI H; FUKUTANI H; KATO Y; OGURI T; YAMAMORI S; AKATSUKA Y; KODERA Y; OHNO R
    CLONAL ANALYSIS OF MULTIPLE POINT MUTATIONS IN THE N-RAS GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    Japanese journal of cancer research
    
    K. Kubo et al., "CLONAL ANALYSIS OF MULTIPLE POINT MUTATIONS IN THE N-RAS GENE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA", Japanese journal of cancer research, 84(4), 1993, pp. 379-387
91. MATSUOKA A; MIYAMURA K; EMI N; TAHARA T; TANIMOTO M; NAOE T; OHNO R; KAKIZUKA A; EVANS RM; SAITO H
    UNEXPECTED HETEROGENEITY OF PML RAR-ALPHA FUSED MESSENGER-RNA DETECTED BY NESTED POLYMERASE CHAIN-REACTION IN ACUTE PROMYELOCYTIC LEUKEMIA/
    Leukemia
    
    A. Matsuoka et al., "UNEXPECTED HETEROGENEITY OF PML RAR-ALPHA FUSED MESSENGER-RNA DETECTED BY NESTED POLYMERASE CHAIN-REACTION IN ACUTE PROMYELOCYTIC LEUKEMIA/", Leukemia, 7(8), 1993, pp. 1151-1155
92. OHNO R; YOSHIDA H; FUKUTANI H; NAOE T; OHSHIMA T; KYO T; ENDOH N; FUJIMOTO T; KOBAYASHI T; HIRAOKA A; MIZOGUCHI H; KODERA Y; SUZUKI H; HIRANO M; AKIYAMA H; AOKI N; SHINDO H; YOKOMAKU S
    MULTIINSTITUTIONAL STUDY OF ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATION THERAPY OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA
    Leukemia
    
    R. Ohno et al., "MULTIINSTITUTIONAL STUDY OF ALL-TRANS-RETINOIC ACID AS A DIFFERENTIATION THERAPY OF REFRACTORY ACUTE PROMYELOCYTIC LEUKEMIA", Leukemia, 7(11), 1993, pp. 1722-1727
93. SAKAGAMI H; UTSUMI A; FUJINAGA S; TAKEDA M; NAOE T; KAWAZOE Y
    STIMULATION OF IODINATION AND CYTOKINE PRODUCTION BY DEHYDROGENATION POLYMERS OF PHENYLPROPENOIDS
    Anticancer research
    
    H. Sakagami et al., "STIMULATION OF IODINATION AND CYTOKINE PRODUCTION BY DEHYDROGENATION POLYMERS OF PHENYLPROPENOIDS", Anticancer research, 13(4), 1993, pp. 1001-1006
94. KIYOI H; NAOE T; YAMAUCHI T; FUKATANI H; KUBO K; KOJIMA S; OHNO R
    MINIMAL RESIDUAL DISEASE STATUS IN PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION - ASSESSMENT OF THE ANTILEUKEMIC EFFECTS OF CHEMOTHERAPY AND BMT
    Leukemia research
    
    H. Kiyoi et al., "MINIMAL RESIDUAL DISEASE STATUS IN PRE-B ACUTE LYMPHOBLASTIC-LEUKEMIAPATIENTS AFTER CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION - ASSESSMENT OF THE ANTILEUKEMIC EFFECTS OF CHEMOTHERAPY AND BMT", Leukemia research, 17(8), 1993, pp. 677-684
95. ASANOMA M; TAKAHASHI K; NAOE T; YAMAMOTO K; MIYABE M; KAWAZOE Y
    SUPPRESSIVE EFFECT OF SOME SYNTHETIC LIGNINS ON CHEMICAL MUTAGENESIS IN SALMONELLA-TYPHIMURIUM AND ON SKIN TUMORIGENESIS PROMOTED BY TPA INMICE
    MUTATION RESEARCH
    
    M. Asanoma et al., "SUPPRESSIVE EFFECT OF SOME SYNTHETIC LIGNINS ON CHEMICAL MUTAGENESIS IN SALMONELLA-TYPHIMURIUM AND ON SKIN TUMORIGENESIS PROMOTED BY TPA INMICE", MUTATION RESEARCH, 292(3), 1993, pp. 261-262
96. OHNO R; KOBAYASHI T; TANIMOTO M; HIRAOKA A; IMAI K; ASOU N; TOMONAGA M; TSUBAKI K; TAKAHASHI I; KODERA Y; YOSHIDA M; MURAKAMI H; NAOE T; SHIMOYAMA M; TSUKADA T; TAKEO T; TESHIMA H; ONOZAWA Y; FUJIMOTO K; KURIYAMA K; HORIUCHI A; KIMURA I; MINAMI S; MIURA Y; KAGEYAMA S; TAHARA T; MASAOKA T; SHIRAKAWA S; SAITO H
    RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT VINCRISTINE, AND OF MAINTENANCE INTENSIFICATION THERAPY BETWEEN 4 OR 12 COURSES IN ADULT ACUTE MYELOID-LEUKEMIA - AML-87 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP
    Cancer
    
    R. Ohno et al., "RANDOMIZED STUDY OF INDIVIDUALIZED INDUCTION THERAPY WITH OR WITHOUT VINCRISTINE, AND OF MAINTENANCE INTENSIFICATION THERAPY BETWEEN 4 OR 12 COURSES IN ADULT ACUTE MYELOID-LEUKEMIA - AML-87 STUDY OF THE JAPAN ADULT LEUKEMIA STUDY-GROUP", Cancer, 71(12), 1993, pp. 3888-3895
97. NAOE T; KUBO K; KIYOI H; OHNO R; AKAO Y; YOSHIDA J; KATO K; KOJIMA S; MATSUYAMA T
    INVOLVEMENT OF THE MLL ALL-1 GENE ASSOCIATED WITH MULTIPLE POINT MUTATIONS OF THE N-RAS GENE IN ACUTE MYELOID-LEUKEMIA WITH T(11 17)(Q23 Q25)/
    Blood
    
    T. Naoe et al., "INVOLVEMENT OF THE MLL ALL-1 GENE ASSOCIATED WITH MULTIPLE POINT MUTATIONS OF THE N-RAS GENE IN ACUTE MYELOID-LEUKEMIA WITH T(11 17)(Q23 Q25)/", Blood, 82(7), 1993, pp. 2260-2261
98. KUNISHIMA S; KOBAYASHI S; TAKAGI A; NAOE T; OHNO R
    RAPID DETECTION OF PLASMA GLYCOCALICIN BY A LATEX AGGLUTINATION-TEST - A USEFUL ADJUNCT IN THE DIFFERENTIAL-DIAGNOSIS OF THROMBOCYTOPENIA
    American journal of clinical pathology
    
    S. Kunishima et al., "RAPID DETECTION OF PLASMA GLYCOCALICIN BY A LATEX AGGLUTINATION-TEST - A USEFUL ADJUNCT IN THE DIFFERENTIAL-DIAGNOSIS OF THROMBOCYTOPENIA", American journal of clinical pathology, 100(5), 1993, pp. 579-584
99. ICHIHASHI T; KUBO K; NAOE T; OHNO R
    NUCLEOTIDE-SEQUENCES OF THE VARIABLE REGIONS OF A HUMAN MONOCLONAL-ANTIBODY AGAINST HLA-A1, A23, AND A24
    Tissue antigens
    
    T. Ichihashi et al., "NUCLEOTIDE-SEQUENCES OF THE VARIABLE REGIONS OF A HUMAN MONOCLONAL-ANTIBODY AGAINST HLA-A1, A23, AND A24", Tissue antigens, 41(5), 1993, pp. 249-254
100. KUBO K; TACHINO J; YAMAGUCHI H; KURACHI T; NAOE T; OHNO R; UEDA K
     A HUMAN MONOCLONAL-ANTIBODY THAT DETECTS HLA-A1-ANTIGENS, A23-ANTIGENS AND A24-ANTIGENS
     Tissue antigens
     
     K. Kubo et al., "A HUMAN MONOCLONAL-ANTIBODY THAT DETECTS HLA-A1-ANTIGENS, A23-ANTIGENS AND A24-ANTIGENS", Tissue antigens, 41(4), 1993, pp. 186-189